Please enable JavaScript to continue using this application.

Compare $ABSI vs $SRPT | Chartloom

Compare

$ABSI vs $SRPT

Absci Corp · Sarepta Therapeutics Inc

ABSI

Absci Corp

SRPT

Sarepta Therapeutics Inc

Compare $ABSI vs $SRPT

Comparing Absci Corp and Sarepta Therapeutics Inc

ABSIAbsci Corp

SRPTSarepta Therapeutics Inc

ABSIAbsci Corp

Market cap

$1.72B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

486.99x

Rev growth (TTM)

-62.3%

YTD performance

181.4%

52W performance

143.1%

FCF yield

-6.4%

SRPTSarepta Therapeutics Inc

Market cap

$1.88B

P/E (TTM)

—

Forward P/E (NTM)

46.80x

Forward P/S (NTM)

1.31x

Rev growth (TTM)

-20.4%

YTD performance

-16.2%

52W performance

-23.7%

FCF yield

4.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABSI

SRPT

Detailed metrics comparison

ABSI

Absci Corp

SRPT

Sarepta Therapeutics Inc

Market Cap

ABSI$1.72B

SRPT$1.88B

Enterprise Value

ABSI$1.61B

SRPT$2.16B

Price

ABSI$10.16

SRPT$17.85

P/E Ratio

ABSIN/A

SRPTN/A

P/S Ratio

ABSI1,098.99x

SRPT0.95x

EV/Sales

ABSI1,029.98x

SRPT1.09x

EV/EBITDA

ABSI0.00x

SRPT12.13x

P/B Ratio

ABSI7.72x

SRPT1.21x

P/FCF Ratio

ABSIN/A

SRPT25.00x

EV/FCF

ABSI-14.73x

SRPT28.66x

PEG Ratio

ABSIN/A

SRPTN/A

Forward P/E (NTM)

ABSIN/A

SRPT46.80x

Forward P/S (NTM)

ABSI486.99x

SRPT1.31x

Revenue (TTM)

ABSI$2M

SRPT$1.97B

Revenue Growth (YoY)

ABSI-62.3%

SRPT-20.4%

Forward Rev Growth

ABSI359.4%

SRPT-23.2%

Gross Margin (TTM)

ABSI0.0%

SRPT67.5%

Operating Margin (TTM)

ABSI0.0%

SRPT0.0%

EBITDA Margin (TTM)

ABSI-7700.6%

SRPT7.5%

Net Margin (TTM)

ABSI-7756.4%

SRPT-6.9%

FCF Margin (TTM)

ABSI-6994.2%

SRPT3.8%

Net Income (TTM)

ABSI$-121M

SRPT$-137M

FCF (TTM)

ABSI$-109M

SRPT$75M

EPS (TTM)

ABSI-$0.77

SRPT-$1.30

ROE (TTM)

ABSI-5921.0%

SRPT-996.0%

ROA (TTM)

ABSI-5231.0%

SRPT-414.0%

ROIC (TTM)

ABSI-5901.0%

SRPT-605.0%

Cash

ABSI$108M

SRPT$571M

Debt

ABSI$150K

SRPT$848M

Net Cash/Debt

ABSI$108M

SRPT$-276M

Current Ratio (TTM)

ABSI10.63x

SRPT4.42x

Quick Ratio (TTM)

ABSI10.26x

SRPT2.57x

Debt/Equity (TTM)

ABSI0.00x

SRPT0.55x

Debt/Assets (TTM)

ABSI0.0%

SRPT0.0%

Interest Coverage (TTM)

ABSIN/A

SRPTN/A

Net Debt/EBITDA (TTM)

ABSI0.00x

SRPT0.00x

Beta

ABSI2.17

SRPT0.46

52W Performance

ABSI143.1%

SRPT-23.7%

YTD Performance

ABSI181.4%

SRPT-16.2%

% from 52W High

ABSI-15.7%

SRPT-27.7%

% from 52W Low

ABSI353.6%

SRPT21.6%

Asset Turnover (TTM)

ABSI0.01x

SRPT0.60x

FCF Yield (TTM)

ABSI-6.4%

SRPT4.0%

Earnings Yield (TTM)

ABSI-7.1%

SRPT-7.3%

Dividend Yield (TTM)

ABSIN/A

SRPTN/A

Rule of 40

ABSI-7,056.5

SRPT-16.6

EV/GP/RG

ABSIN/A

SRPTN/A

Ticker research

View ABSI research View SRPT research

Metric	ABSI Absci Corp	SRPT Sarepta Therapeutics Inc
Market & Valuation
Market Cap	$1.72B	$1.88B
Enterprise Value	$1.61B	$2.16B
Price	$10.16	$17.85
P/E Ratio	N/A	N/A
P/S Ratio	1,098.99x	0.95x
EV/Sales	1,029.98x	1.09x
EV/EBITDA	0.00x	12.13x
P/B Ratio	7.72x	1.21x
P/FCF Ratio	N/A	25.00x
EV/FCF	-14.73x	28.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	46.80x
Forward P/S (NTM)	486.99x	1.31x
Revenue & Growth
Revenue (TTM)	$2M	$1.97B
Revenue Growth (YoY)	-62.3%	-20.4%
Forward Rev Growth	359.4%	-23.2%
Profitability
Gross Margin (TTM)	0.0%	67.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7700.6%	7.5%
Net Margin (TTM)	-7756.4%	-6.9%
FCF Margin (TTM)	-6994.2%	3.8%
Net Income (TTM)	$-121M	$-137M
FCF (TTM)	$-109M	$75M
EPS (TTM)	-$0.77	-$1.30
ROE (TTM)	-5921.0%	-996.0%
ROA (TTM)	-5231.0%	-414.0%
ROIC (TTM)	-5901.0%	-605.0%
Financial Health
Cash	$108M	$571M
Debt	$150K	$848M
Net Cash/Debt	$108M	$-276M
Current Ratio (TTM)	10.63x	4.42x
Quick Ratio (TTM)	10.26x	2.57x
Debt/Equity (TTM)	0.00x	0.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.17	0.46
52W Performance	143.1%	-23.7%
YTD Performance	181.4%	-16.2%
% from 52W High	-15.7%	-27.7%
% from 52W Low	353.6%	21.6%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.60x
FCF Yield (TTM)	-6.4%	4.0%
Earnings Yield (TTM)	-7.1%	-7.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7,056.5	-16.6
EV/GP/RG	N/A	N/A
Ticker research	View ABSI research	View SRPT research

Valuation

P/S Ratio

SRPT

0.95x

ABSI

1,098.99x

EV/FCF

ABSI

-14.73x

SRPT

28.66x

Growth & revenue

Revenue Growth TTM

SRPT

-20.4%

ABSI

-62.3%

Forward Revenue Growth

ABSI

359.4%

SRPT

-23.2%

Profitability & performance

Gross Margin

SRPT

67.5%

ABSI

0.0%

ROE

SRPT

-996.0%

ABSI

-5921.0%

FCF Yield %

SRPT

4.0%

ABSI

-6.4%

52-Week Performance

ABSI

143.1%

SRPT

-23.7%

Detailed metrics comparison

ABSI

Absci Corp

SRPT

Sarepta Therapeutics Inc

Market Cap

ABSI$1.72B

SRPT$1.88B

Enterprise Value

ABSI$1.61B

SRPT$2.16B

Price

ABSI$10.16

SRPT$17.85

P/E Ratio

ABSIN/A

SRPTN/A

P/S Ratio

ABSI1,098.99x

SRPT0.95x

EV/Sales

ABSI1,029.98x

SRPT1.09x

EV/EBITDA

ABSI0.00x

SRPT12.13x

P/B Ratio

ABSI7.72x

SRPT1.21x

P/FCF Ratio

ABSIN/A

SRPT25.00x

EV/FCF

ABSI-14.73x

SRPT28.66x

PEG Ratio

ABSIN/A

SRPTN/A

Forward P/E (NTM)

ABSIN/A

SRPT46.80x

Forward P/S (NTM)

ABSI486.99x

SRPT1.31x

Revenue (TTM)

ABSI$2M

SRPT$1.97B

Revenue Growth (YoY)

ABSI-62.3%

SRPT-20.4%

Forward Rev Growth

ABSI359.4%

SRPT-23.2%

Gross Margin (TTM)

ABSI0.0%

SRPT67.5%

Operating Margin (TTM)

ABSI0.0%

SRPT0.0%

EBITDA Margin (TTM)

ABSI-7700.6%

SRPT7.5%

Net Margin (TTM)

ABSI-7756.4%

SRPT-6.9%

FCF Margin (TTM)

ABSI-6994.2%

SRPT3.8%

Net Income (TTM)

ABSI$-121M

SRPT$-137M

FCF (TTM)

ABSI$-109M

SRPT$75M

EPS (TTM)

ABSI-$0.77

SRPT-$1.30

ROE (TTM)

ABSI-5921.0%

SRPT-996.0%

ROA (TTM)

ABSI-5231.0%

SRPT-414.0%

ROIC (TTM)

ABSI-5901.0%

SRPT-605.0%

Cash

ABSI$108M

SRPT$571M

Debt

ABSI$150K

SRPT$848M

Net Cash/Debt

ABSI$108M

SRPT$-276M

Current Ratio (TTM)

ABSI10.63x

SRPT4.42x

Quick Ratio (TTM)

ABSI10.26x

SRPT2.57x

Debt/Equity (TTM)

ABSI0.00x

SRPT0.55x

Debt/Assets (TTM)

ABSI0.0%

SRPT0.0%

Interest Coverage (TTM)

ABSIN/A

SRPTN/A

Net Debt/EBITDA (TTM)

ABSI0.00x

SRPT0.00x

Beta

ABSI2.17

SRPT0.46

52W Performance

ABSI143.1%

SRPT-23.7%

YTD Performance

ABSI181.4%

SRPT-16.2%

% from 52W High

ABSI-15.7%

SRPT-27.7%

% from 52W Low

ABSI353.6%

SRPT21.6%

Asset Turnover (TTM)

ABSI0.01x

SRPT0.60x

FCF Yield (TTM)

ABSI-6.4%

SRPT4.0%

Earnings Yield (TTM)

ABSI-7.1%

SRPT-7.3%

Dividend Yield (TTM)

ABSIN/A

SRPTN/A

Rule of 40

ABSI-7,056.5

SRPT-16.6

EV/GP/RG

ABSIN/A

SRPTN/A

Ticker research

View ABSI research View SRPT research

Metric	ABSI Absci Corp	SRPT Sarepta Therapeutics Inc
Market & Valuation
Market Cap	$1.72B	$1.88B
Enterprise Value	$1.61B	$2.16B
Price	$10.16	$17.85
P/E Ratio	N/A	N/A
P/S Ratio	1,098.99x	0.95x
EV/Sales	1,029.98x	1.09x
EV/EBITDA	0.00x	12.13x
P/B Ratio	7.72x	1.21x
P/FCF Ratio	N/A	25.00x
EV/FCF	-14.73x	28.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	46.80x
Forward P/S (NTM)	486.99x	1.31x
Revenue & Growth
Revenue (TTM)	$2M	$1.97B
Revenue Growth (YoY)	-62.3%	-20.4%
Forward Rev Growth	359.4%	-23.2%
Profitability
Gross Margin (TTM)	0.0%	67.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-7700.6%	7.5%
Net Margin (TTM)	-7756.4%	-6.9%
FCF Margin (TTM)	-6994.2%	3.8%
Net Income (TTM)	$-121M	$-137M
FCF (TTM)	$-109M	$75M
EPS (TTM)	-$0.77	-$1.30
ROE (TTM)	-5921.0%	-996.0%
ROA (TTM)	-5231.0%	-414.0%
ROIC (TTM)	-5901.0%	-605.0%
Financial Health
Cash	$108M	$571M
Debt	$150K	$848M
Net Cash/Debt	$108M	$-276M
Current Ratio (TTM)	10.63x	4.42x
Quick Ratio (TTM)	10.26x	2.57x
Debt/Equity (TTM)	0.00x	0.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.17	0.46
52W Performance	143.1%	-23.7%
YTD Performance	181.4%	-16.2%
% from 52W High	-15.7%	-27.7%
% from 52W Low	353.6%	21.6%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.60x
FCF Yield (TTM)	-6.4%	4.0%
Earnings Yield (TTM)	-7.1%	-7.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-7,056.5	-16.6
EV/GP/RG	N/A	N/A
Ticker research	View ABSI research	View SRPT research